Trials / Completed
CompletedNCT03462290
Botox Injections for Patients With Persistent Facial Pain
Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Patients With Persistent Idiopathic Facial Pain: a Randomized, Double-blind, Cross- Over, Placebo-controlled Pilot Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Norwegian University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to investigate efficacy and safety of injecting botulinum toxin towards the sphenopalatine ganglion using MultiGuide in patients with persistent idiopathic facial pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | botulinum toxin type A | Botulinum toxin type A, powder for solution, 25 international units (IU), injected towards the sphenopalatine ganglion using MultiGuide |
| DRUG | placebo | solution without botulinum toxin A, injected towards the sphenopalatine ganglion using MultiGuide |
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2021-11-23
- Completion
- 2021-11-23
- First posted
- 2018-03-12
- Last updated
- 2021-12-17
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT03462290. Inclusion in this directory is not an endorsement.